Purchases and Sales Made in Q4 2023 in Edgewise Therapeutics, Inc. (EWTX)
This table provides information about the institutional ownership of Edgewise Therapeutics, Inc. (EWTX) during Q4 2023. The information is specifically focused on institutions that hold shares of Edgewise Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-86.3K- 57.15% |
$476K - $1.04M
|
64.7K
$1.7M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-118K- 74.72% |
$653K - $1.43M
|
40.1K
$1.05M
|
|
|
Feb 14, 2024
Q4 2023
|
Opaleye Management Inc.
Boston, MA |
SELL
|
- |
-176K- 20.15% |
$972K - $2.13M
|
699K
$18.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-182K- 6.56% |
$1M - $2.2M
|
2.59M
$67.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-213K- 7.74% |
$1.17M - $2.58M
|
2.54M
$66.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-395K- 13.4% |
$2.18M - $4.78M
|
2.55M
$67M
|